ERBB2 and breast carcinoma: CDK12 can promote the occurrence of HER2-positive breast cancer by promoting the expression of cathepsin E, and DHRS9 and CD247 can protect against HER2-positive breast cancer by reducing cathepsin E expression (Figure 4B).